Literature DB >> 11760396

Synovial fluid cytokine levels in Behçet's disease.

I Ertenli1, S Kiraz, M Calgüneri, I Celik, M Erman, I C Haznedaroglu, S Kirazli.   

Abstract

OBJECTIVE: To investigate the synovial fluid levels of interleukin-1 beta (IL-1 beta), tumour necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF-beta), IL-1 receptor antagonist (IL-1ra), soluble IL-2 receptor (sIL-2r) and IL-8 in patients with Behçet's disease (BD) and to compare them to levels in rheumatoid arthritis (RA), and osteoarthritis (OA).
METHODS: The cytokine levels of BD (n = 14), RA (n = 15) and OA (n = 15) patients were assessed by enzyme-linked immunosorbent method.
RESULTS: Median synovial IL-1 beta and TNF-alpha levels were higher in RA compared to BD and OA patients. IL-1 beta levels were also higher in BD than OA whereas TNF levels were similar in these two groups. IL-1ra and TGF-beta activity in BD were higher than OA but lower than RA. sIL-2r and IL-8 levels were increased in BD and RA in comparison to OA patients.
CONCLUSION: The arthritis of BD is non-erosive and accordingly, its synovial fluid contains lower levels of cytokines primarily involved in cartilage destruction, namely IL-1 beta and TNF-alpha, than RA. IL-1ra and TGF might serve as protective factors against erosion in the inflamed joints. High synovial fluid levels of sIL-2r and IL-8 probably reflect a non-specific inflammatory process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11760396

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  16 in total

1.  Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behçet's disease.

Authors:  M Akif Oztürk; Ihsan Ertenli; Sedat Kiraz; Ibrahim C Haznedaroğlu; Ismail Celik; Serafettin Kirazli; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2003-05-15       Impact factor: 2.631

2.  Different ELR (+) angiogenic CXC chemokine profiles in synovial fluid of patients with Behçet's disease, familial Mediterranean fever, rheumatoid arthritis, and osteoarthritis.

Authors:  Hakan Erdem; Salih Pay; Muhittin Serdar; Ismail Simşek; Ayhan Dinç; Uğur Muşabak; Aysel Pekel; Mustafa Turan
Journal:  Rheumatol Int       Date:  2004-11-03       Impact factor: 2.631

3.  Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

Authors:  Salih Pay; Hakan Erdem; Aysel Pekel; Ismail Simsek; Ugur Musabak; Ali Sengul; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

4.  Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease.

Authors:  Suleyman Serdar Koca; Murat Kara; Firat Deniz; Metin Ozgen; Caner Feyzi Demir; Nevin Ilhan; Ahmet Isik
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 5.  Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.

Authors:  Salih Pay; Ismail Simşek; Hakan Erdem; Ayhan Dinç
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

6.  Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.

Authors:  Fuat Duygulu; Cem Evereklioglu; Mustafa Calis; Murat Borlu; Mustafa Cekmen; Ozcan Ascioglu
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

7.  Extensive erosive arthropathy in a patient with Behçet's disease: case report.

Authors:  Gülümser Aydin; Işik Keleş; Ebru Atalar; Sevim Orkun
Journal:  Clin Rheumatol       Date:  2005-06-04       Impact factor: 2.980

8.  Ultrasonographic Measurement of the Femoral Cartilage Thickness in Patients with Behçet's Disease.

Authors:  I Batmaz; M Kara; T Tiftik; M Yildiz; R Çevik; L Özçakar
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

9.  [Comments on the pathogenesis of Behçet's disease. A key to understanding new therapies?].

Authors:  U Pleyer; D Hazirolan; N Stübiger
Journal:  Ophthalmologe       Date:  2012-06       Impact factor: 1.059

10.  Role of polymorphisms in Adamantiades-Behçet's disease.

Authors:  Virginia G Kaklamani; Maureen Sadim; Yvoni Koumantaki; Phedon Kaklamanis; Boris Pasche
Journal:  J Rheumatol       Date:  2008-10-15       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.